BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31174180)

  • 21. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
    Endo M; Doi R; Nishita M; Minami Y
    J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ROR1, an embryonic protein with an emerging role in cancer biology.
    Borcherding N; Kusner D; Liu GH; Zhang W
    Protein Cell; 2014 Jul; 5(7):496-502. PubMed ID: 24752542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
    Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
    Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma.
    Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim BH
    Ann Diagn Pathol; 2015 Oct; 19(5):330-4. PubMed ID: 26245996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis.
    Saleh RR; Peinado P; Fuentes-Antrás J; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
    Front Oncol; 2019; 9():1040. PubMed ID: 31681578
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development.
    Matsuda T; Nomi M; Ikeya M; Kani S; Oishi I; Terashima T; Takada S; Minami Y
    Mech Dev; 2001 Jul; 105(1-2):153-6. PubMed ID: 11429290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential subcellular localization of Ror tyrosine kinase receptors in cultured astrocytes.
    Paganoni S; Anderson KL; Ferreira A
    Glia; 2004 May; 46(4):456-66. PubMed ID: 15095375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded.
    Lyashenko N; Weissenböck M; Sharir A; Erben RG; Minami Y; Hartmann C
    Dev Dyn; 2010 Aug; 239(8):2266-77. PubMed ID: 20593419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia.
    Shaheen I; Ibrahim N
    Fetal Pediatr Pathol; 2012 Jun; 31(3):113-9. PubMed ID: 22369092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains.
    Bainbridge TW; DeAlmeida VI; Izrael-Tomasevic A; Chalouni C; Pan B; Goldsmith J; Schoen AP; Quiñones GA; Kelly R; Lill JR; Sandoval W; Costa M; Polakis P; Arnott D; Rubinfeld B; Ernst JA
    PLoS One; 2014; 9(7):e102695. PubMed ID: 25029443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
    Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
    Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
    Qi X; Okinaka Y; Nishita M; Minami Y
    Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia.
    Aghebati-Maleki L; Shabani M; Baradaran B; Motallebnezhad M; Majidi J; Yousefi M
    Biomed Pharmacother; 2017 Apr; 88():814-822. PubMed ID: 28160756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Backbone and side-chain chemical shift assignments of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1).
    Ma X; Zhang Y; Liu B; Yang J; Hu K
    Biomol NMR Assign; 2018 Apr; 12(1):145-148. PubMed ID: 29313214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.
    Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J
    PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular, functional, and gene expression analysis of zebrafish Ror1 receptor.
    Bai Y; Liu C; Zhou J; Rong X; Wang H
    Fish Physiol Biochem; 2019 Feb; 45(1):355-363. PubMed ID: 30242697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.
    Zhang S; Chen L; Wang-Rodriguez J; Zhang L; Cui B; Frankel W; Wu R; Kipps TJ
    Am J Pathol; 2012 Dec; 181(6):1903-10. PubMed ID: 23041612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
    Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S
    Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.